Consultant
CurrentGlobal market access strategy development and implementation, with particular focus on rare disease and orphan drugs. Recent and ongoing projects:- Global market access strategy for first-in-class neuroscience therapy in Phase II - Global market access strategy and implementation for innovative rare genetic disease therapy in Phase III preparing for global launch- Global market access strategy for Phase II orphan drug in a rare, genetically-driven haematologic disease- Global market access support for new indication for marketed orphan drug in ultra-rare paediatric disease- Presentation on best practice in Global Market Access for Top 10 pharma company- Mentor for UK Cancer Tech Accelerator programme for oncology researchers and academics seeking to form start-ups, sponsored by Cancer Research UK and Roche